CIK 0001262104 · Non-accelerated filer<br>Smaller reporting company
Lite Strategy, Inc.
Sign in to watch- Ticker
- LITS
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510407811
- Phone
- 858-369-7100
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- MEI Pharma, Inc., MARSHALL EDWARDS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-12-21 | Baltic Charles V. III Director | Purchase | +1,700 | $7.17 | $12K | 1,700 |
| 2012-12-21 | Baltic Charles V. III Director | Purchase | +1,800 | $7.19 | $13K | 4,300 |
| 2012-12-21 | Baltic Charles V. III Director | Purchase | +1,700 | $7.17 | $12K | 6,000 |
| 2012-12-06 | Rueckert William Dodge Director | Other acquisition · Warrants to purchase shares of common stock | +2,988,672 | 2,991,506 | ||
| 2012-12-06 | AUSTIN JOSIAH T 10% owner | Other acquisition · Warrants to purchase shares of common stock | +1,000,000 | 1,000,000 | ||
| 2012-12-06 | Rueckert William Dodge Director | Other acquisition · Warrants to purchase shares of common stock | +2,988,672 | 2,989,380 | ||
| 2012-12-03 | AUSTIN JOSIAH T 10% owner | Other acquisition | +3,478,245 | 3,832,081 | ||
| 2012-12-03 | NOVOGEN LTD 10% owner | Other disposition | −17,837,246 | 0 | ||
| 2012-11-20 | NOVOGEN LTD 10% owner | Conversion | +4,827,000 | 17,837,246 | ||
| 2012-11-20 | NOVOGEN LTD 10% owner | Conversion · Series A Convert Preferred Stock, par value $0.01 per share | −1,000 | 0 | ||
| 2012-11-16 | GOLD DANIEL P PHD Chief Executive Officer | Grant or award · Options to purchase shares of common stock | +300,000 | 720,390 | ||
| 2012-11-16 | GOLD DANIEL P PHD Chief Executive Officer | Grant or award · Options to purchase shares of common stock | −300,000 | 720,390 | ||
| 2012-09-21 | Cann Leah Rush Director | Grant or award · Options to purchase shares of common stock | +23,810 | 48,979 | ||
| 2012-09-21 | Baltic Charles V. III Director | Grant or award · Options to purchase shares of common stock | +23,810 | 48,979 | ||
| 2012-09-21 | Rueckert William Dodge Director | Grant or award · Options to purchase shares of common stock | +23,810 | 48,979 | ||
| 2012-09-21 | White Christine Anna Director | Grant or award · Options to purchase shares of common stock | +23,810 | 48,979 | ||
| 2012-09-21 | Williams Bryan Director | Grant or award · Options to purchase shares of common stock | +23,810 | 48,979 | ||
| 2012-08-07 | GOLD DANIEL P PHD Chief Executive Officer | Grant or award · Options to purchase shares of common stock | +100,000 | 420,390 | ||
| 2012-08-07 | Mass Robert D. Chief Medical Officer | Grant or award · Options to purchase shares of common stock | +232,359 | 409,979 | ||
| 2012-08-07 | Zech Thomas M. Chief Financial Officer | Grant or award · Options to purchase shares of common stock | +75,000 | 175,000 |
Page 15 of 17 · 337 trades